Compared with controls, patients with MASH demonstrated a higher nuclear SHP ratio (51.7% vs. 1.55%, p <0.001), which correlated with the severity of hepatitis and steatosis, but not with serum BA levels. Here, NR0B2 is linked to metabolic dysfunction-associated steatohepatitis.